RECEPTOR SELECTIVE CANCER CHEMOPREVENTIVE RETINOIDS
RECEPTOR SELECTIVE CANCER CHEMOPREVENTIVE RETINOIDS
批准号:
3094477
负责人:
MARCIA I. DAWSON
金额:
$101.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-05-01 至 1996-04-30
中文摘要
维甲酸预防和逆转肿瘤转化过程和
抑制肿瘤的促进作用。然而,全身毒性和致畸性
阻碍了天然和合成维甲酸的开发,因为它们是有用的
用于化学预防癌症的药物。具有身份标识的
维甲酸核受体家族及其新发现
它们对基因表达的影响,维甲酸在血管内皮细胞的作用机制
现在可以研究分子水平了。我们建议开发受体-
维甲酸及其拮抗剂在化学预防致癌中的应用
在上皮组织中。维甲酸结果的相关性
特异性RARs的转录激活和结合亲和力
类维甲酸结构和调节细胞分化的能力
复杂的系统对于维甲酸的有效设计是无价的,它具有
增强了化学预防效果。在本计划中,项目包括
四个综合研究项目和一个生物检测核心,我们提出这个
方法:(1)基于结构的维甲酸类化合物的设计与合成。
活动相关性(项目I),(2)理论研究,涉及
生物测定结果的结构-活性和多变量分析
每个受体的最佳药效团(项目II),(3)
核受体如何介导视黄醇反应的研究
视黄醇受体功能激活的评估(项目III),(4)
三维结构的X射线结晶学研究
来定义配体结合域的几何形状的受体
RAR(项目IV),以及(5)RAR结合亲和力的测定,以及
受体选择性维甲酸的活性和细胞毒性评价
在上皮细胞培养试验中(锚定非依赖性抑制
JB6表皮细胞的生长及人鳞状细胞癌SCC13的分化
癌细胞),然后进行抑制诱导的分析。
肿瘤促进剂在小鼠表皮中表达的肿瘤标志物鸟氨酸脱羧酶
和对小鼠的毒性(生物测定核心)。候选人的适宜性
作为化学预防药物进一步开发的化合物将是
使用决策网络方法建立的。一支公认的团队
科学家和临床医生将作为科学顾问小组提供帮助
引导研究进展。
英文摘要
Retinoids prevent and reverse the process of neoplastic transformation and
inhibit tumor promotion. However, systemic toxicity and teratogenicity
have hindered the development of natural and synthetic retinoids as useful
drugs for the chemoprevention of cancer. With the identification of the
family of nuclear retinoic acid receptors (RARs) and the discoveries of
their effects on gene expression, the mechanism of retinoid action at the
molecular level can now be investigated. We propose to develop receptor-
specific retinoids and antagonists for chemoprevention of cancers induced
in epithelial tissues. Correlations of the results of retinoid
transcriptional activation of and binding affinity for specific RARs with
retinoid structure and the ability to regulate cell differentiation in more
complex systems are invaluable for the efficient design of retinoids having
enhanced chemopreventive effectiveness. In this Program Project comprising
four integrated Research Projects and a Bioassay Core, we propose this
approach, namely: (1) design and synthesis of retinoids based on structure-
activity correlations (Project I), (2) theoretical studies involving
structure-activity and multivariate analyses of bioassay results to define
the optimum pharmacophore for each receptor (Project II), (3)
investigations of how nuclear receptors mediate the retinoid response and
evaluation of retinoid functional activation of the RARs (Project III), (4)
X-ray crystallographic investigations of the three-dimensional structures
of the receptors to define the geometry of the ligand-binding domain for
the RARs (Project IV), and (5) determination of RAR binding affinity, and
evaluation of the activity and cytotoxicity of receptor-selective retinoids
in epithelial cell culture assays (inhibition of anchorage-independent
growth of JB6 epidermal cells and differentiation of SCC13 human squamous
carcinoma cells), followed by assays for the inhibition of induction of the
tumor marker ornithine decarboxylase in mouse epidermis by tumor promoters
and toxicity in the mouse (Bioassay Core). The suitability of candidate
compounds for further development as chemopreventive agents will be
established using a decision network method. A team of recognized
scientists and clinicians will serve as a Scientific Advisory Panel to help
guide research Progress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LRH-1 Antagonism: Impact on Estrogen-dependent Breast Cancer
-
批准号:8597538
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2012
-
负责人:MARCIA I. DAWSON
-
依托单位:
LRH-1 Antagonism: Impact on Estrogen-dependent Breast Cancer
-
批准号:8442839
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2012
-
负责人:MARCIA I. DAWSON
-
依托单位:
LRH-1 Antagonism: Impact on Estrogen-dependent Breast Cancer
-
批准号:8221038
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2012
-
负责人:MARCIA I. DAWSON
-
依托单位:
Rexinoid Synergy in Prostate Cancer Apoptosis
-
批准号:7559992
-
项目类别:
-
资助金额:$52.96万
-
财政年份:2005
-
负责人:MARCIA I. DAWSON
-
依托单位:
Rexinoid Synergy in Prostate Cancer Apoptosis
-
批准号:6871910
-
项目类别:
-
资助金额:$46.02万
-
财政年份:2005
-
负责人:MARCIA I. DAWSON
-
依托单位:
Rexinoid Synergy in Prostate Cancer Apoptosis
-
批准号:7174308
-
项目类别:
-
资助金额:$49.18万
-
财政年份:2005
-
负责人:MARCIA I. DAWSON
-
依托单位:
Rexinoid Synergy in Prostate Cancer Apoptosis
-
批准号:7347571
-
项目类别:
-
资助金额:$51.04万
-
财政年份:2005
-
负责人:MARCIA I. DAWSON
-
依托单位:
Rexinoid Synergy in Prostate Cancer Apoptosis
-
批准号:7014084
-
项目类别:
-
资助金额:$49.12万
-
财政年份:2005
-
负责人:MARCIA I. DAWSON
-
依托单位:
RETINOID DESIGN AND SYNTHESIS
-
批准号:6491802
-
项目类别:
-
资助金额:$25.62万
-
财政年份:2001
-
负责人:MARCIA I. DAWSON
-
依托单位:
RETINOID DESIGN AND SYNTHESIS
-
批准号:6598844
-
项目类别:
-
资助金额:$25.62万
-
财政年份:2001
-
负责人:MARCIA I. DAWSON
-
依托单位:
RETINOID DESIGN AND SYNTHESIS
-
批准号:6102598
-
项目类别:
-
资助金额:$25.62万
-
财政年份:1999
-
负责人:MARCIA I. DAWSON
-
依托单位:
RETINOID DESIGN AND SYNTHESIS
-
批准号:6300357
-
项目类别:
-
资助金额:$25.62万
-
财政年份:1999
-
负责人:MARCIA I. DAWSON
-
依托单位:
RETINOID DESIGN AND SYNTHESIS
-
批准号:6269430
-
项目类别:
-
资助金额:$21.12万
-
财政年份:1998
-
负责人:MARCIA I. DAWSON
-
依托单位:
RETINOID DESIGN AND SYNTHESIS
-
批准号:6237118
-
项目类别:
-
资助金额:$30.06万
-
财政年份:1997
-
负责人:MARCIA I. DAWSON
-
依托单位:
MICHELLAMINE B ANALOGS FOR TREATMENT OF HIV INFECTION
-
批准号:2667747
-
项目类别:
-
资助金额:$9.04万
-
财政年份:1996
-
负责人:MARCIA I. DAWSON
-
依托单位:
MICHELLAMINE B ANALOGS FOR TREATMENT OF HIV INFECTION
-
批准号:2073041
-
项目类别:
-
资助金额:$26.12万
-
财政年份:1996
-
负责人:MARCIA I. DAWSON
-
依托单位:
MICHELLAMINE B ANALOGS FOR TREATMENT OF HIV INFECTION
-
批准号:2376382
-
项目类别:
-
资助金额:$26.96万
-
财政年份:1996
-
负责人:MARCIA I. DAWSON
-
依托单位:
MICHELLAMINE B ANALOGS FOR TREATMENT OF HIV INFECTION
-
批准号:6040611
-
项目类别:
-
资助金额:$18.79万
-
财政年份:1996
-
负责人:MARCIA I. DAWSON
-
依托单位:
RECEPTOR SELECTIVE CANCER CHEMOPREVENTIVE RETINOIDS
-
批准号:2094513
-
项目类别:
-
资助金额:$103.79万
-
财政年份:1991
-
负责人:MARCIA I. DAWSON
-
依托单位:
RECEPTOR SELECTIVE CANCER CHEMOPREVENTIVE RETINOIDS
-
批准号:3094476
-
项目类别:
-
资助金额:$97.72万
-
财政年份:1991
-
负责人:MARCIA I. DAWSON
-
依托单位:
海外基金